The best investment your clinical trial will ever make.
In the sprint to hit your clinical trial’s milestones, minutes matter. The average Phase 2 interventional research study spends roughly $330,000 per day — that’s $33,000 per working hour in a 10-hour day, or $550 per minute. By extension, the average cost of enlisting Clinical Enrollment’s patient quality services amounts to 2-3 days, but at a trial acceleration rate that averages around 60 days, that’s a 30x return on investment.
- WE’RE CHANGING RECRUITMENT |
- WE’RE CHANGING RECRUITMENT |
- WE’RE CHANGING RECRUITMENT |
- WE’RE CHANGING RECRUITMENT |
- WE’RE CHANGING RECRUITMENT |
- WE’RE CHANGING RECRUITMENT |
- WE’RE CHANGING RECRUITMENT |
- WE’RE CHANGING RECRUITMENT |
Potential side effects of working with Clinical Enrollment
We create unparalleled results, with social targeting spanning across a wide range of platforms, tapping directly into relevant, high quality patient communities. Here’s what our Sponsor clients can expect to experience.
$19.2M
average savings by enlisting Clinical Enrollment
57 DAYS
CE closes enrollment an average of nearly 2 months faster
4.4x
increase in recruitment speed
18%
decrease in screen fail rates
32%
under-represented patient population rate
2x
site effectiveness. If your trial expects to enroll one patient per month, we’ll make it two.
How We Do It
We provide white glove clinical site handling, providing them with full patient info, EHRs & scheduling data to help streamline their workload and be responsive to their needs.
We draw interested parties to a conversion-centric website — which features engaging, emotion-driven messaging — where progressing through the screening process is simple and actionable.
We target on every social platform, eschewing traditional database-led recruitment constraints and increasing our audience reach exponentially.
Therapeutic Areas Of Expertise
Here are some of the areas in which Clinical Enrollment excels.
Central Nervous System (CNS)
We’re experienced at crafting honest, informative content for conditions such as Alzheimer’s and Parkinson’s disease, as well as creating loved-one-specific messaging targeted to caretakers, who are also deeply affected by these diagnoses.
Pediatric Therapies
Providing a personal, hand-holding approach for younger patients navigating the clinical research landscape, as well as effectively engaging parents, guardians, and caretakers who are helping guide their care.
Autoimmune diseases
We align your study with FDA guidelines and are industry-leading in speaking to diverse patient audiences, as represented by our 32 percent under-represented recruitment population.
Oncology
CE helps patients access clinical research as a care option via an innovative treatment landscape, advanced well beyond market-approved therapies.
Rare/Orphan Disease
From CAR T-cell therapy to gene therapy all the way through research-leading medical device options, our cutting-edge behavioral targeting allows us to find even the smallest patient populations to participate in clinical work.
Pain management
We understand how to ask patients about their pain in the most intuitive, effective way possible, including expertise in patient pain scoring to best match them with applicable trials.
Dermatological condition
CE provides access to innovative therapies within patient communities for whom invasive standard of care treatment options have typically been the only options available.
IRD/Ophthalmology
As a company founded with origins in ophthalmological research, CE is uniquely positioned to speak directly with inherited retinal dystrophy patient communities.
Approved therapies / Go to market strategy
We use Clinical Enrollment’s content and patient identification expertise to get FDA-approved therapies into the hands of patients and healthcare providers.
Exclusion criteria
There will always be reasons not to do something. Respectfully, we beg to differ.
Exclusion
our sites told us they can do it, why do I need Clinical Enrollment?
Exclusion
our sites told us they can do it, why do I need Clinical Enrollment?
Inclusion
There are currently 4x more clinical trials recruiting than there were in 2019, but from a patient pool whose size hasn’t grown along with it. In a world where nearly 85% of interventional clinical trials are missing milestones by at least a month, and because of an RFP “overpromise gap” that hovers around 47%, you just can’t rely on 10-year-old databases to find patients. Best case scenario you’ll end up with only 25% of the people you need, and that’s just not going to cut it.
Exclusion
We don’t have the budget for it.
Exclusion
We don’t have the budget for it.
Inclusion
Generally, an interventional clinical trial costs around $10M per month, or more than $330,000 per day. By extension, enlisting Clinical Enrollment’s services speeds up recruitment by around 57-60 days, or two months, which if you do the math saves sponsors roughly $20M in cash burn. So the question isn’t, “How can we afford this?” more accurately it would be, “How can we afford not to?”
Exclusion
We’ve been burned by vendors in the past.
Exclusion
We’ve been burned by vendors in the past.
Inclusion
Clinical Enrollment’s success-based pricing model means that, from a drug sponsor perspective, utilizing our services is risk free. We derive payment on a signed Informed Consent Form basis only, which means that until a mutually agreed upon number of randomizations is hit, we don’t get paid. Thus, we assume all of the risk, and our clients are free to focus on running — and completing — their trial.
Exclusion
But we already do social ads, how will this be different?
Exclusion
But we already do social ads, how will this be different?
Inclusion
Candidly, people tell us they have social covered all the time, but when we really dive in, we’re able to see the full picture. Searching for Facebook ads for a clinical trial in the oncology space, you’ll see less than 50. Weight loss — which is the single biggest clinical trial category in the country? You might see a few hundred, tops. However, search for social ads for socks, for example, and Facebook stops counting at 50,000. Our finely-honed strategic approach identifies the right messaging and the right mass coverage to get the reach your trial needs to cross the finish line, it’s that simple.
Exclusion
Our clinical sites typically don’t like working with outside vendors.
Exclusion
Our clinical sites typically don’t like working with outside vendors.
Inclusion
We’ve worked with hundreds of sites, and have made a point during that time to really listen to them. We know when they’re understaffed because research study staff are on vacation, for example, and can scale back on our referral volume during that window so as not to overwhelm the site. We’ve heard what medical information is most useful to them, and during our double-screening process, ensure that the exact data they need is what they will receive. Clinical Enrollment maintains a responsive, respectful relationship dynamic with your sites and one that has been cultivated collaboratively over time, with the end goal always being to provide the highest quality patients.
Exclusion
But we’re already halfway through our trial…
Exclusion
But we’re already halfway through our trial…
Inclusion
When sites get all the way through their rolodex of potential candidates and recruitment has stalled, that’s when we do our best work. We come in and infuse the enrollment process with an influx of fresh blood (no pun intended) to get things supercharged.
Exclusion
It sounds like it works, but will it work for me?
Exclusion
It sounds like it works, but will it work for me?
Inclusion
We’ve worked in treatment areas from oncology to neurodegenerative conditions, dermatology to ophthalmology, and have demonstrated efficacy and expertise across the board. In fact, potential clients need only to take a look at our case studies for past successes and proven wins — the Clinical Enrollment difference is real.
Get Started
Need highly-targeted clinical trial participants? Let’s work together.